The New York Times highlights the Undiagnosed Disease Network.
Researchers have developed a new Alzheimer's disease mouse model with greater genetic diversity.
A sequencing-based analysis of sphingomonas infections at the National Institute of Health's Clinical Center traced them to patient sinks, Stat News reports.
New drugs, tests, and policies suggest steady and continued future growth in the space, though public awareness of personalized medicine continues to lag.
A workshop concludes that for some studies there is no good alternative to using human fetal tissue, ScienceInsider reports.
A partial US government shutdown would affect scientific research, Nature News says.
The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.
Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.
ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.
The company will donate the Infinium Global Diversity array it developed for the program to the three All of Us genome centers to process up to 1 million samples.
23andMe is offering early customers re-testing on newer chips for a fee, Wired reports.
He Jiankui is no longer affiliated with Direct Genomics Biotechnology, the single molecule sequencing company he founded, Nikkei Asian Review reports.
Newsweek writes about the hopes for precision medicine in cancer, but also challenges getting it to patients.
In Genome Research this week: genomic architecture of glioblastoma, predictive computational approach to estimate SNP fitness, and more.